Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-06-17
1992-05-26
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514810, 514811, 514812, A01M 4350
Patent
active
051168596
ABSTRACT:
Anxiolytic and antipsychotic treatment is provided to patients by administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-immidazolyl)-am ino]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 3342826 (1967-09-01), Miller et al.
patent: 4210660 (1980-07-01), Takashima et al.
patent: 4835172 (1989-05-01), Acker et al.
patent: 4887780 (1989-10-01), Vega-Noverola et al.
Drugs, vol. 25, pp. 463-464 (1983).
Pharmacology Biochemistry & Behavior, vol. 15, pp. 695-699 (1981).
Neuropharmacology, vol. 26, No. 2/3, pp. 195-200 (1987).
Annals of the New York Academy of Sciences, vol. 95, pp. 315-335 (1962).
Pharmacology Biochemistry & Behavior, vol. 32, pp. 777-785 (1989).
Acher Jacques
Costall Brenda
Gardaix-Luthereau Renee
Monier Jean-Claude
Naylor Robert
Criares T. J.
Laboratoires Delagrange Societe d'Application Pharmacodynamiques
Waddell Frederick E.
LandOfFree
Method of providing anxiolytic and antipsychotic treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of providing anxiolytic and antipsychotic treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of providing anxiolytic and antipsychotic treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-420114